Association of 3-, 6- and 12-month eGFR and proteinuria with death-censored graft failure
. | Univariable . | Adjusted . | ||
---|---|---|---|---|
. | HR (95% CI) . | P-value . | HR (95% CI) . | P-value . |
eGFR variables | ||||
3 months | ||||
For 10 mL/min/1.73 m² increase | 0.76 (0.67–0.85) | <0.0001 | 0.80 (0.70–0.92) | 0.001 |
<0.0001 | <0.0001 | |||
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.83 (0.51–1.36) | 0.46 | 0.83 (0.50–1.38) | 0.47 |
30–45 | 1.29 (0.82–2.03) | 0.27 | 1.14 (0.68–1.91) | 0.63 |
<30 | 4.60 (2.78–7.62) | <0.0001 | 3.65 (2.00–6.65) | <0.0001 |
<45 mL/min/1.73 m2 | 1.98 (1.42–2.74) | <0.0001 | 1.66 (1.14–2.40) | 0.008 |
6 months | ||||
For 10 mL/min/1.73 m² increase | 0.80 (0.71–0.91) | 0.0004 | 0.84 (0.74–0.97) | 0.013 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.88 (0.53–1.43) | 0.60 | 0.88 (0.53–1.47) | 0.63 |
30–45 | 1.15 (0.72–1.85) | 0.55 | 1.10 (0.66–1.85) | 0.71 |
<30 | 3.88 (2.31–6.53) | <0.0001 | 3.27 (1.76–6.06) | 0.0002 |
<45 mL/min/1.73 m2 | 1.73 (1.23–2.43) | 0.002 | 1.51 (1.04–2.20) | 0.031 |
12 months | ||||
For 10 mL/min/1.73 m² increase | 0.67 (0.59–0.77) | <0.0001 | 0.69 (0.60–0.80) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 1.03 (0.60–1.77) | 0.90 | 1.08 (0.62–1.87) | 0.78 |
30–45 | 1.46 (0.87–2.45) | 0.16 | 1.41 (0.81–2.47) | 0.22 |
<30 | 7.12 (4.13–12.28) | <0.0001 | 6.86 (3.72–12.67) | <0.0001 |
<45 mL/min/1.73 m2 | 2.21 (1.55–3.13) | <0.0001 | 1.95 (1.33–2.86) | 0.0006 |
Proteinuria variables | ||||
3 months | ||||
For 1 g/day increase | 1.24 (1.14–1.34) | <0.0001 | 1.25 (1.14–1.36) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 1.89 (1.14–3.12) | 0.013 | 1.78 (1.06–2.98) | 0.028 |
1–2 | 3.64 (1.93–6.87) | <0.0001 | 2.85 (1.45–5.58) | 0.002 |
>2 | 5.31 (2.81–10.02) | <0.0001 | 4.89 (2.56–9.33) | <0.0001 |
>0.5 g/day | 2.69 (1.84–3.94) | <0.0001 | 2.45 (1.65–3.63) | <0.0001 |
6 months | ||||
For 1 g/day increase | 1.41 (1.27–1.57) | <0.0001 | 1.42 (1.27–1.59) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 2.70 (1.63–4.49) | 0.0001 | 2.53 (1.51–4.25) | 0.0004 |
1–2 | 7.51 (4.35–12.94) | <0.0001 | 6.33 (3.61–11.09) | <0.0001 |
>2 | 3.46 (1.49–8.04) | 0.004 | 3.55 (1.51–8.37) | 0.004 |
>0.5 g/day | 3.85 (2.59–5.72) | <0.0001 | 3.56 (2.38–5.34) | <0.0001 |
12 months | ||||
For 1 g/day increase | 1.60 (1.43–1.79) | <0.0001 | 1.57 (1.38–1.77) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 3.13 (1.92–5.11) | <0.0001 | 2.56 (1.53–4.31) | 0.0004 |
1–2 | 4.98 (2.86–8.69) | <0.0001 | 4.34 (2.45–7.70) | <0.0001 |
>2 | 7.29 (3.72–14.30) | <0.0001 | 5.87 (2.91–11.81) | <0.0001 |
>0.5 g/day | 4.04 (2.75–5.92) | <0.0001 | 3.39 (2.25–5.11) | <0.0001 |
. | Univariable . | Adjusted . | ||
---|---|---|---|---|
. | HR (95% CI) . | P-value . | HR (95% CI) . | P-value . |
eGFR variables | ||||
3 months | ||||
For 10 mL/min/1.73 m² increase | 0.76 (0.67–0.85) | <0.0001 | 0.80 (0.70–0.92) | 0.001 |
<0.0001 | <0.0001 | |||
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.83 (0.51–1.36) | 0.46 | 0.83 (0.50–1.38) | 0.47 |
30–45 | 1.29 (0.82–2.03) | 0.27 | 1.14 (0.68–1.91) | 0.63 |
<30 | 4.60 (2.78–7.62) | <0.0001 | 3.65 (2.00–6.65) | <0.0001 |
<45 mL/min/1.73 m2 | 1.98 (1.42–2.74) | <0.0001 | 1.66 (1.14–2.40) | 0.008 |
6 months | ||||
For 10 mL/min/1.73 m² increase | 0.80 (0.71–0.91) | 0.0004 | 0.84 (0.74–0.97) | 0.013 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.88 (0.53–1.43) | 0.60 | 0.88 (0.53–1.47) | 0.63 |
30–45 | 1.15 (0.72–1.85) | 0.55 | 1.10 (0.66–1.85) | 0.71 |
<30 | 3.88 (2.31–6.53) | <0.0001 | 3.27 (1.76–6.06) | 0.0002 |
<45 mL/min/1.73 m2 | 1.73 (1.23–2.43) | 0.002 | 1.51 (1.04–2.20) | 0.031 |
12 months | ||||
For 10 mL/min/1.73 m² increase | 0.67 (0.59–0.77) | <0.0001 | 0.69 (0.60–0.80) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 1.03 (0.60–1.77) | 0.90 | 1.08 (0.62–1.87) | 0.78 |
30–45 | 1.46 (0.87–2.45) | 0.16 | 1.41 (0.81–2.47) | 0.22 |
<30 | 7.12 (4.13–12.28) | <0.0001 | 6.86 (3.72–12.67) | <0.0001 |
<45 mL/min/1.73 m2 | 2.21 (1.55–3.13) | <0.0001 | 1.95 (1.33–2.86) | 0.0006 |
Proteinuria variables | ||||
3 months | ||||
For 1 g/day increase | 1.24 (1.14–1.34) | <0.0001 | 1.25 (1.14–1.36) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 1.89 (1.14–3.12) | 0.013 | 1.78 (1.06–2.98) | 0.028 |
1–2 | 3.64 (1.93–6.87) | <0.0001 | 2.85 (1.45–5.58) | 0.002 |
>2 | 5.31 (2.81–10.02) | <0.0001 | 4.89 (2.56–9.33) | <0.0001 |
>0.5 g/day | 2.69 (1.84–3.94) | <0.0001 | 2.45 (1.65–3.63) | <0.0001 |
6 months | ||||
For 1 g/day increase | 1.41 (1.27–1.57) | <0.0001 | 1.42 (1.27–1.59) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 2.70 (1.63–4.49) | 0.0001 | 2.53 (1.51–4.25) | 0.0004 |
1–2 | 7.51 (4.35–12.94) | <0.0001 | 6.33 (3.61–11.09) | <0.0001 |
>2 | 3.46 (1.49–8.04) | 0.004 | 3.55 (1.51–8.37) | 0.004 |
>0.5 g/day | 3.85 (2.59–5.72) | <0.0001 | 3.56 (2.38–5.34) | <0.0001 |
12 months | ||||
For 1 g/day increase | 1.60 (1.43–1.79) | <0.0001 | 1.57 (1.38–1.77) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 3.13 (1.92–5.11) | <0.0001 | 2.56 (1.53–4.31) | 0.0004 |
1–2 | 4.98 (2.86–8.69) | <0.0001 | 4.34 (2.45–7.70) | <0.0001 |
>2 | 7.29 (3.72–14.30) | <0.0001 | 5.87 (2.91–11.81) | <0.0001 |
>0.5 g/day | 4.04 (2.75–5.92) | <0.0001 | 3.39 (2.25–5.11) | <0.0001 |
Models were adjusted for recipient age, history of heart failure, donor type, DGF, immunization, HLA incompatibilities, induction treatment and graft rejection (prior to the considered variable, i.e. prior to 3, 6 or 12 months).
Association of 3-, 6- and 12-month eGFR and proteinuria with death-censored graft failure
. | Univariable . | Adjusted . | ||
---|---|---|---|---|
. | HR (95% CI) . | P-value . | HR (95% CI) . | P-value . |
eGFR variables | ||||
3 months | ||||
For 10 mL/min/1.73 m² increase | 0.76 (0.67–0.85) | <0.0001 | 0.80 (0.70–0.92) | 0.001 |
<0.0001 | <0.0001 | |||
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.83 (0.51–1.36) | 0.46 | 0.83 (0.50–1.38) | 0.47 |
30–45 | 1.29 (0.82–2.03) | 0.27 | 1.14 (0.68–1.91) | 0.63 |
<30 | 4.60 (2.78–7.62) | <0.0001 | 3.65 (2.00–6.65) | <0.0001 |
<45 mL/min/1.73 m2 | 1.98 (1.42–2.74) | <0.0001 | 1.66 (1.14–2.40) | 0.008 |
6 months | ||||
For 10 mL/min/1.73 m² increase | 0.80 (0.71–0.91) | 0.0004 | 0.84 (0.74–0.97) | 0.013 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.88 (0.53–1.43) | 0.60 | 0.88 (0.53–1.47) | 0.63 |
30–45 | 1.15 (0.72–1.85) | 0.55 | 1.10 (0.66–1.85) | 0.71 |
<30 | 3.88 (2.31–6.53) | <0.0001 | 3.27 (1.76–6.06) | 0.0002 |
<45 mL/min/1.73 m2 | 1.73 (1.23–2.43) | 0.002 | 1.51 (1.04–2.20) | 0.031 |
12 months | ||||
For 10 mL/min/1.73 m² increase | 0.67 (0.59–0.77) | <0.0001 | 0.69 (0.60–0.80) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 1.03 (0.60–1.77) | 0.90 | 1.08 (0.62–1.87) | 0.78 |
30–45 | 1.46 (0.87–2.45) | 0.16 | 1.41 (0.81–2.47) | 0.22 |
<30 | 7.12 (4.13–12.28) | <0.0001 | 6.86 (3.72–12.67) | <0.0001 |
<45 mL/min/1.73 m2 | 2.21 (1.55–3.13) | <0.0001 | 1.95 (1.33–2.86) | 0.0006 |
Proteinuria variables | ||||
3 months | ||||
For 1 g/day increase | 1.24 (1.14–1.34) | <0.0001 | 1.25 (1.14–1.36) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 1.89 (1.14–3.12) | 0.013 | 1.78 (1.06–2.98) | 0.028 |
1–2 | 3.64 (1.93–6.87) | <0.0001 | 2.85 (1.45–5.58) | 0.002 |
>2 | 5.31 (2.81–10.02) | <0.0001 | 4.89 (2.56–9.33) | <0.0001 |
>0.5 g/day | 2.69 (1.84–3.94) | <0.0001 | 2.45 (1.65–3.63) | <0.0001 |
6 months | ||||
For 1 g/day increase | 1.41 (1.27–1.57) | <0.0001 | 1.42 (1.27–1.59) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 2.70 (1.63–4.49) | 0.0001 | 2.53 (1.51–4.25) | 0.0004 |
1–2 | 7.51 (4.35–12.94) | <0.0001 | 6.33 (3.61–11.09) | <0.0001 |
>2 | 3.46 (1.49–8.04) | 0.004 | 3.55 (1.51–8.37) | 0.004 |
>0.5 g/day | 3.85 (2.59–5.72) | <0.0001 | 3.56 (2.38–5.34) | <0.0001 |
12 months | ||||
For 1 g/day increase | 1.60 (1.43–1.79) | <0.0001 | 1.57 (1.38–1.77) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 3.13 (1.92–5.11) | <0.0001 | 2.56 (1.53–4.31) | 0.0004 |
1–2 | 4.98 (2.86–8.69) | <0.0001 | 4.34 (2.45–7.70) | <0.0001 |
>2 | 7.29 (3.72–14.30) | <0.0001 | 5.87 (2.91–11.81) | <0.0001 |
>0.5 g/day | 4.04 (2.75–5.92) | <0.0001 | 3.39 (2.25–5.11) | <0.0001 |
. | Univariable . | Adjusted . | ||
---|---|---|---|---|
. | HR (95% CI) . | P-value . | HR (95% CI) . | P-value . |
eGFR variables | ||||
3 months | ||||
For 10 mL/min/1.73 m² increase | 0.76 (0.67–0.85) | <0.0001 | 0.80 (0.70–0.92) | 0.001 |
<0.0001 | <0.0001 | |||
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.83 (0.51–1.36) | 0.46 | 0.83 (0.50–1.38) | 0.47 |
30–45 | 1.29 (0.82–2.03) | 0.27 | 1.14 (0.68–1.91) | 0.63 |
<30 | 4.60 (2.78–7.62) | <0.0001 | 3.65 (2.00–6.65) | <0.0001 |
<45 mL/min/1.73 m2 | 1.98 (1.42–2.74) | <0.0001 | 1.66 (1.14–2.40) | 0.008 |
6 months | ||||
For 10 mL/min/1.73 m² increase | 0.80 (0.71–0.91) | 0.0004 | 0.84 (0.74–0.97) | 0.013 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 0.88 (0.53–1.43) | 0.60 | 0.88 (0.53–1.47) | 0.63 |
30–45 | 1.15 (0.72–1.85) | 0.55 | 1.10 (0.66–1.85) | 0.71 |
<30 | 3.88 (2.31–6.53) | <0.0001 | 3.27 (1.76–6.06) | 0.0002 |
<45 mL/min/1.73 m2 | 1.73 (1.23–2.43) | 0.002 | 1.51 (1.04–2.20) | 0.031 |
12 months | ||||
For 10 mL/min/1.73 m² increase | 0.67 (0.59–0.77) | <0.0001 | 0.69 (0.60–0.80) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
>60 mL/min/1.73 m² (reference) | 1.00 | – | 1.00 | – |
45–60 | 1.03 (0.60–1.77) | 0.90 | 1.08 (0.62–1.87) | 0.78 |
30–45 | 1.46 (0.87–2.45) | 0.16 | 1.41 (0.81–2.47) | 0.22 |
<30 | 7.12 (4.13–12.28) | <0.0001 | 6.86 (3.72–12.67) | <0.0001 |
<45 mL/min/1.73 m2 | 2.21 (1.55–3.13) | <0.0001 | 1.95 (1.33–2.86) | 0.0006 |
Proteinuria variables | ||||
3 months | ||||
For 1 g/day increase | 1.24 (1.14–1.34) | <0.0001 | 1.25 (1.14–1.36) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 1.89 (1.14–3.12) | 0.013 | 1.78 (1.06–2.98) | 0.028 |
1–2 | 3.64 (1.93–6.87) | <0.0001 | 2.85 (1.45–5.58) | 0.002 |
>2 | 5.31 (2.81–10.02) | <0.0001 | 4.89 (2.56–9.33) | <0.0001 |
>0.5 g/day | 2.69 (1.84–3.94) | <0.0001 | 2.45 (1.65–3.63) | <0.0001 |
6 months | ||||
For 1 g/day increase | 1.41 (1.27–1.57) | <0.0001 | 1.42 (1.27–1.59) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 2.70 (1.63–4.49) | 0.0001 | 2.53 (1.51–4.25) | 0.0004 |
1–2 | 7.51 (4.35–12.94) | <0.0001 | 6.33 (3.61–11.09) | <0.0001 |
>2 | 3.46 (1.49–8.04) | 0.004 | 3.55 (1.51–8.37) | 0.004 |
>0.5 g/day | 3.85 (2.59–5.72) | <0.0001 | 3.56 (2.38–5.34) | <0.0001 |
12 months | ||||
For 1 g/day increase | 1.60 (1.43–1.79) | <0.0001 | 1.57 (1.38–1.77) | <0.0001 |
– | <0.0001 | – | <0.0001 | |
<0.5 g/day (reference) | 1.00 | – | 1.00 | – |
0.5–1 | 3.13 (1.92–5.11) | <0.0001 | 2.56 (1.53–4.31) | 0.0004 |
1–2 | 4.98 (2.86–8.69) | <0.0001 | 4.34 (2.45–7.70) | <0.0001 |
>2 | 7.29 (3.72–14.30) | <0.0001 | 5.87 (2.91–11.81) | <0.0001 |
>0.5 g/day | 4.04 (2.75–5.92) | <0.0001 | 3.39 (2.25–5.11) | <0.0001 |
Models were adjusted for recipient age, history of heart failure, donor type, DGF, immunization, HLA incompatibilities, induction treatment and graft rejection (prior to the considered variable, i.e. prior to 3, 6 or 12 months).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.